XM does not provide services to residents of the United States of America.

Lawsuit claims Miley Cyrus copied Bruno Mars song for hit 'Flowers'



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Lawsuit claims Miley Cyrus copied Bruno Mars song for hit 'Flowers'</title></head><body>

By Blake Brittain

Sept 17 (Reuters) -Pop star Miley Cyrus copied fellow megastar Bruno Mars' hit "When I Was Your Man" in her number-one single "Flowers," according to a copyright lawsuit filed in California federal court.

The complaint, filed on Monday by music-rights owner Tempo Music Investments, said that "Flowers" duplicates "numerous melodic, harmonic and lyrical elements" of Mars' song, which topped the Billboard Hot 100 in 2013.

Spokespeople for Cyrus' label Sony Music 6758.T and attorneys and spokespeople for Tempo did not immediately respond to a request for comment on the lawsuit on Tuesday.

Mars is not a party in the lawsuit, and spokespeople for his label, Warner Music Group's WMG.O Atlantic Records, declined to comment. Tempo said in the complaint that it bought its share of "When I Was Your Man" from the song's co-writer Philip Lawrence in 2020.

The lawsuit also accused streaming-service owners including Apple AAPL.O and Amazon AMZN.O and retailers including Target TGT.N and Walmart WMT.N of infringing Tempo's copyright by distributing Cyrus' song. Spokespeople for the companies did not immediately respond to requests for comment.

Cyrus released "Flowers" on her 2023 album "Endless Summer Vacation." "Flowers" has more than 1 billion streams on Spotify and won the Grammy award for Song of the Year in 2024.

Tempo's lawsuit said that "Flowers" has "striking similarities" to "When I Was Your Man," including melodies, bass lines, chord progressions and lyrical elements. It also cited a Billboard article from 2023, which said that "any listener can detect that [Mars' song] boasts a chorus that is the inverse of what Cyrus sings on 'Flowers.'"

Tempo asked the court for an unspecified amount of monetary damages and an order blocking the alleged infringement.



Reporting by Blake Brittain in Washington
Editing by David Bario and Tomasz Janowski

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.